Corcept Therapeutics
CORT
#2411
Rank
A$9.49 B
Marketcap
$90.66
Share price
9.76%
Change (1 day)
126.49%
Change (1 year)

Corcept Therapeutics (CORT) - P/B ratio

P/B ratio as of November 2024 : 9.85

According to Corcept Therapeutics 's latest financial reports the company has a price-to-book ratio of 10.0132.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Corcept Therapeutics - P/B ratio (from 2004 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-316.6151.66%
2022-12-314.36-28.38%
2021-12-316.084.75%
2020-12-315.8155.51%
2019-12-313.73-32.97%
2018-12-315.57-48.39%
2017-12-3110.8-44.6%
2016-12-3119.5-34%
2015-12-3129.5-132.88%
2014-12-31-89.8-688.73%
2013-12-3115.3560.05%
2012-12-312.31-72.08%
2011-12-318.28-37.09%
2010-12-3113.267.34%
2009-12-317.86161.86%
2008-12-313.00-63.8%
2007-12-318.2966.66%
2006-12-314.9860.13%
2005-12-313.110.9%
2004-12-313.08
2003-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
5.35-45.65%๐Ÿ‡บ๐Ÿ‡ธ USA
6.40-35.06%๐Ÿ‡บ๐Ÿ‡ธ USA
4.90-50.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
55.6 464.21%๐Ÿ‡บ๐Ÿ‡ธ USA
1.73-82.41%๐Ÿ‡บ๐Ÿ‡ธ USA
5.98-39.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.31-113.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-8.71-188.39%๐Ÿ‡บ๐Ÿ‡ธ USA
2.37-75.94%๐Ÿ‡บ๐Ÿ‡ธ USA